Physician profile
Liana Proffer
NPI 1891770046
$1,302.20
in general payments reported to CMS, 2019-2025
14 companies · $428 in 2025
The $428 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $26.81 · 2021: $40.97 · 2022: $348 · 2023: $236 · 2024: $108 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $127.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $412.41 | 2022-2023 | |
| Revance Therapeutics, INC. | $248.26 | 2024-2025 | Daxxify |
| Abbvie INC. | $127.51 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $118.63 | 2025 | Iovera, Exparel |
| Lifenet Health | $89.05 | 2023 | |
| Tepha INC | $61.60 | 2019 | |
| Allergan, INC. | $57.61 | 2019-2021 | |
| Baudax Bio INC. | $47.28 | 2022 | |
| Genentech USA, INC. | $41.67 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $27.56 | 2025 | |
| Galderma Laboratories, L.P. | $21.71 | 2022 | |
| Misonix INC | $21.14 | 2021 | |
| Mimedx Group, INC. | $14.59 | 2024 | |
| Kerecis Limited | $13.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liana Proffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.